Roger Tieu, PhD

Why did you choose the University of Pittsburgh?

The University of Pittsburgh was a fitting choice for me given its rich history in immunology with pioneers such as Jonas Salk, the creator of the polio vaccine, and Thomas Starzl, who revolutionized the field of transplant immunology. In my eyes, the PMI represents an impressive graduate program that continues to evolve and has trained exceptional students that include MSTP students. Moreover, it is immediately clear that the faculty here are open and collaborative, which provides great training opportunities and fosters interdisciplinary work. Overall, these qualities and attributes led me to choose the University of Pittsburgh to be where I train as a physician-scientist.

Education & Training

  • PhD in Microbiology & Immunology, University of Pittsburgh School of Medicine, 2022
  • BS in Biology and Chemistry, Emory University, 2015

Research Interests

Transplant immunology; immunological memory; T cell biology; signaling

Publications

Abou-Daya, K. I., Tieu, R., Zhao, D., Rammal, R., Sacirbegovic, F., Williams, A. L., Shlomchik, W. D., Oberbarnscheidt, M. H., & Lakkis, F. G. (2021). Resident memory T cells form during persistent antigen exposure leading to allograft rejection. Science Immunology, 6(57), eabc8122.

Hughes, A. D., Zhao, D., Dai, H., Abou-Daya, K. I., Tieu, R., Rammal, R., Williams, A. L., Landsittel, D. P., Shlomchik, W. D., Morelli, A. E., Oberbarnscheidt, M. H., & Lakkis, F. G. (2019). Cross-dressed dendritic cells sustain effector T cell responses in islet and kidney allografts. Journal of Clinical Investigation, 130(1), 287–294. 

Tieu, R., Lakkis, F. G., & Oberbarnscheidt, M. H. (2016). Getting down and dirty: Germ-exposed lab mice as a model of the adult human immune system. Transplantation, 100(12), 2490.

Tieu, R., Amancha, P. K., & Villinger, F. (2015). Targeting TIM-3 to reverse immune exhaustion during chronic viral infection. Emory University.

Tieu, R., Amancha, P. K., Villinger, F., & Byrareddy, S. N. (2014). TIM-3, a possible target for immunotherapy in cancer and chronic viral infections. Austin Virology and Retro Virology, 1(2).

Luo, X., Huang, L., Han, L., Luo, Z., Hu, F., Tieu, R., & Gan, L. (2014). Systematic prioritization and integrative analysis of copy number variations in schizophrenia reveal key schizophrenia susceptibility genes. Schizophrenia Bulletin, 40(6), 1285–1299.

Luo, X., Deng, M., Xie, X., Huang, L., Wang, H., Jiang, L., Liang, G., Hu, F., Tieu, R., Chen, R., & Gan, L. (2013). GATA3 controls the specification of prosensory domain and neuronal survival in the mouse cochlea. Human Molecular Genetics, 22(18), 3609–3623.